Per-protocol analyses, however, suggested a nonsignificant trend toward a lower prevalence of long COVID at two months (OR, 0 ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
GlobalData on MSN
Mirum concludes Phase III EXPAND trial enrolment for Livmarli
The double-blind, randomised, placebo-controlled trial will assess the efficacy and safety of Livmarli in both children and ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation by Dr. Laurence Klotz discussing initial perioperative outcomes of CAPTAIN, ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results